A First in Class Product that can act as a “Platform” Applicable to Multiple Diseases

ImmCelz®

  • Focused on development and commercialization of the ImmCelz® product
  • ImmCelz® is a therapeutic that utilizes the immune system to concurrently induce regeneration and immune modulation
  • “Regenerative Immunology” is the mechanism of action
  • The product is personalized in that it utilizes cells from the same patient
  • The product is “allogeneically influenced” in that universal donor cells are utilized to reprogram the patient cells
  • Patient cells after “ex vivo” reprogramming are re-introduced

Scientific Conclusions

  • ImmCelz® is first “regenerative immunotherapy”
  • By endowing immune cells with regenerative activity, enhanced distribution is possible due to size differences
  • Personalized aspect provides increased safety
  • Existing immunotherapy protocols and skills allow for rapid integration of ImmCelz® by end users
  • Demonstrated efficacy in several degenerative and autoimmune models
  • Several mechanisms of action elucidate

Indications

Type 1
Diabetes

Learn More

Rheumatoid
Arthritis

Learn More

Liver
Damage

Learn More

Stroke

Learn More

News:

WORLD STEM CELL SUMMIT PRESENTATION 2021​

Contact Us

ImmCelz© 2021 – Creative Medical Technology Holdings, Inc. All rights reserved. ImmCelz® and the ImmCelz® logos are trademarks of Creative Medical Technology Holdings, Inc

Site Links

About

Indications